A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life.
Systemic administration of lidocaine has been widely reported to provide effective analgesia in both cancer and non-malignant pain. We report the use of intravenous lidocaine in the management of cancer-related neuropathic pain and its pivotal role in restoring function and facilitating end-of-life care at home.